Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Electroceuticals are gaining attention as a non-invasive neuromodulation method with the advantages of low risk and low cost, replacing risky and costly invasive brain stimulation. In particular, it is expected to be a safe and effective treatment for treatment-resistant patients who have adverse reactions to existing synthetic or biologic medicines, or whose adherence to medication has decreased significantly due to the long duration of medication.
The target indications for which electroceuticals is being explored are neurological disorders such as depression, anxiety, insomnia, and obsessive-compulsive disorder. More recently, research has expanded to include stroke, Alzheimer's, tinnitus, migraines, Parkinson's, obesity, and genetic disorders such as Charcot Marie Tooth.
For reference, this report focuses on transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), which are technologies being actively developed by domestic manufacturers, and estimates their domestic and international market status, commercialization prospects, and potential sales volume, and does not include a review of patents.
Abbreviations and Acronyms
Disclaimer
Preface
1 Overview
1.1 Definition of Electroceuticals
1.2 Electroceuticals vs. Digital Therapeutics
1.3 Scope of Research
2 Understanding Electroceuticals Technology
2.1 Understanding TMS
2.1.1 Clinical Evidence Development
2.1.2 Treatment Process of rTMS
2.1.3 Latest Technology Trends
2.2 Understanding tDCS
2.2.1 Clinical Evidence Development
2.2.2 Treatment Process of tDCS
3 Current Market of Electroceuticals
3.1 Current Market of Korea
3.1.1 Major Suppliers
3.1.2 Electroceuticals and NHIS
3.1.3 Clinical Trials Approved in Korea
3.2 Global Electroceuticals Market
3.2.1 Major Suppliers
3.2.2 Global Clinical Trials on Electroceuticals
3.2.3 Global Electroceuticals Research & Development
4 Demand Forecast for Electroceuticals
4.1 Electroceuticals by Indication
4.1.1 Depression
4.1.2 Anxiety Disorder
4.1.3 Insomnia
4.1.4 Obsessive-Compulsive Disorder
4.1.5 Addiction
4.2 Market Size of Pharmaceuticals to Electroceuticals' Indications
4.3 Market Drivers and Market Restraints
4.3.1 Market Drivers
4.3.2 Market Restraints
5 Business Strategy Suggestions
5.1 Korean Market Access Strategy
5.2 Global Market Access Strategy
5.3 Conclusion
Appendix 1 Detailed Target Disease Codes
Appendix 2 Non-Reimbursement TMS Charges
Appendix 3 TMS Device FDA Approval Status
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 120 |
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Telecom and IT |
Pages : 111 |
Request Sample 
Request Discount 
Inquire Before Buy
